Janus Henderson Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $181M | Buy |
|
|||||
|
2025
Q2 | $222M | Buy |
|
|||||
|
2025
Q1 | $172M | Buy |
|
|||||
|
2024
Q4 | $40.6M | Sell |
|
|||||
|
2024
Q3 | $37.3M | Buy |
|
|||||
|
2024
Q2 | $63.1M | Sell |
|
|||||
|
2024
Q1 | $77.6M | Sell |
|
|||||
|
2023
Q4 | $71.3M | Sell |
|
|||||
|
2023
Q3 | $136M | Buy |
|
|||||
|
2023
Q2 | $178M | Buy |
|
|||||
|
2023
Q1 | $89.9M | Sell |
|
|||||
|
2022
Q4 | $302M | Sell |
|
|||||
|
2022
Q3 | $787M | Buy |
|
|||||
|
2022
Q2 | $454M | Sell |
|
|||||
|
2022
Q1 | $851M | Sell |
|
|||||
|
2021
Q4 | $976M | Sell |
|
|||||
|
2021
Q3 | $1.43B | Sell |
|
|||||
|
2021
Q2 | $1.22B | Buy |
|
|||||
|
2021
Q1 | $672M | Buy |
|
|||||
|
2020
Q4 | $229M | Buy |
|
|||||
|
2020
Q3 | $201M | Buy |
|
|||||
|
2020
Q2 | $171M | Sell |
|
|||||
|
2020
Q1 | $211M | Buy |
|
|||||
|
2019
Q4 | $128M | Sell |
|
|||||
|
2019
Q3 | $120M | Sell |
|
|||||
|
2019
Q2 | $150M | Sell |
|
|||||
|
2019
Q1 | $173M | Buy |
|
|||||
|
2018
Q4 | $149M | Sell |
|
|||||
|
2018
Q3 | $245M | Sell |
|
|||||
|
2018
Q2 | $422M | Sell |
|
|||||
|
2018
Q1 | $513M | Sell |
|
|||||
|
2017
Q4 | $497M | Sell |
|
|||||
|
2017
Q3 | $432M | Buy |
|
|||||
|
2017
Q2 | $500M | Buy |
|
|||||
|
2017
Q1 | $568K | Hold |
|
|||||
|
2016
Q4 | $401K | Buy |
|